biosciences and healthcare dr. francisco medina gómez jalisco state council of science and...
TRANSCRIPT
![Page 1: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/1.jpg)
Biosciences and Healthcare
Dr. Francisco Medina GómezJalisco State Council of Science and
Technology (COECYTJAL)San Antonio , Texas, November 16th, 2012
![Page 2: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/2.jpg)
Did NAFTA Deliver?
• In manufacturing, YES:– Mexico is a manufacturing powerhouse, on par with
Germany and China– Productivity soared 80% (but has become stagnated)– Mexican exports tripled
• But in the pre_NAFTA hype, it was the services which were expected to grow
• The results are in some cases poor and, in others, disastrous
![Page 3: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/3.jpg)
The Services Sector
• Growth in FDI in retail, banking, tourism• BUT:– Local investment has declined– The wage gap is wider, Mexicans are poorer– Mexico has been unable to grow at an average
accumulated rate of over 2% in the last 20 years– Mexico is as dependent as ever on the U.S. economy,
in spite of a flurry of FTA´s– Mexico was the worst hit Latin American economy
during the recent world crisis
![Page 4: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/4.jpg)
Is NAFTA to blame?• NAFTA´s founding fathers were carried away by trade
hype• Underestimated the stubborn reality of everyday life,
not subject to flimsy, trendy economic models of market vs State
• But if NAFTA did fail to meet the main objective of improving the lives of the majority of Mexicans on the street, it was also because of the dismal failure of four consecutive Mexican Federal Governments to date, to implement sound public policies to promote economic growth, that effectively channels the benefits from trade into other parts of the economy.
![Page 5: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/5.jpg)
México Economy in PerspectiveGDP change 2004-2009
11 AGRICULTURA, GANADERIA, APROVECHAMIENTO FORESTAL, …21 MINERIA
22 ELECTRICIDAD, AGUA Y SUMINISTRO DE GAS POR DUCTOS AL …23 CONSTRUCCION
31 -33 INDUSTRIAS MANUFACTURERA43 COMERCIO AL POR MAYOR46 COMERCIO AL POR MENOR
48 -49 TRANSPORTES, CORREOS Y ALMACENAMIENTO51 INFORMACION EN MEDIOS MASIVOS
52 SERVICIOS FINANCIEROS Y DE SEGUROS53 SERVICIOS INMOBILIARIOS Y DE ALQUILER DE BIENES MUEBLES …
54 SERVICIOS PROFESIONALES, CIENTIFICOS Y TECNICOS55 DIRECCION DE CORPORATIVOS Y EMPRESAS
56 SERVICIOS DE APOYO A LOS NEGOCIOS Y MANEJO DE DESECHOS …61 SERVICIOS EDUCATIVOS
62 SERVICIOS DE SALUD Y DE ASISTENCIA SOCIAL71 SERVICIOS DE ESPARCIMIENTO CULTURALES Y DEPORTIVOS, Y …
72 SERVICIOS DE ALOJAMIENTO TEMPORAL Y DE PREPARACION DE …81 OTROS SERVICIOS EXCEPTO ACTIVIDADES DEL GOBIERNO
0 1,000 2,000
Miles de Millones de Pesos
Valor Agregado Censal Bruto (~PIB)
2009
2004
22.6%139.5%
56.7%101.0%
59.6%10.0%
6.9%48.9%
3.3%47.4%
2.5%45.1%
60.6%87.4%
32.4%60.6%
97.5%70.2%
49.6%
0% 50% 100% 150%
Crecimiento % VACB 04-09
Source: INEGI. Economic Census, 2004, 2009
![Page 6: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/6.jpg)
The exceptions that prove the rule
• Two services sectors have shone brightly of their own accord:– ICT– Health Care
• With, without or even in spite of NAFTA, IT in México is blooming:– From 200 MM USD in 2002 to % Billion in 2012– Over 400,000 jobs created, 100,000 of them
though PROSOFT
![Page 7: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/7.jpg)
ICT• Has created wealth• Has created a burgeoning middle middle C+ and
upper middle class B (50% growth from 2008 to 2010 in Guadalajara alone)
• Uses Mexican brainpower, Mexican talent, availability of plentiful young Mexican IT trained professionals and
• YES!– A Sound Economic Policy: PROSOFT
• Will continue growing at an accelerated 12 – 14% annual rate for the next 10 years
![Page 8: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/8.jpg)
What about Health Care?
• Although this success story is a midget by ICT standards, Health Care is alive and well and poised to become one of the fastest growing sectors in the context of NAFTA
• What are the causes underlying this success?• Specially in a country where Health Care is
considered socialized?
![Page 9: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/9.jpg)
Coming of Age
• Our medical doctors and our specialists are– extremely professional, – extensively trained in clinical practice – A significant number trained abroad– Well versed in applying modern scientific knowledge– technologicaly savvy– Young and sexy– Open to change– And they smile at you!
![Page 10: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/10.jpg)
Investment and Certification
• Our hospitals, both public and private have invested heavily in new equipments, new technologies, including ICT and good practices
• Growing trend to become certified, e.g. the Joint Commission
• Public policies have been successful in promoting health, increasing life expectancy
![Page 11: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/11.jpg)
Major Achievements• All the major health indicators have improved
substantially, infant mortality has dropped • Compared to the appalling failure of Mexico´s
public (and even private) education system, the Health Care Sector has delivered.
• Mexicans now live longer to get the same kind of chronic diseases that US and Canadian citizens have.
• Our morbidity and mortality indicators are not very different from those of our two NAFTA partners.
![Page 12: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/12.jpg)
Seguro Popular• And a sound public policy!• Enter Seguro Popular– With all its shortcomings, a major achievement
• From the Harvard School of Public Health:– Despite periods of economic downturns and crisis, Mexico
recently achieved a significant milestone – enrolling 52.6 million previously uninsured Mexicans in public medical insurance programs and thereby achieving universal health coverage in less than a decade.
– Sure, the public coverage is more basic, and Mexican facilities generally less advanced than their US counterparts. Yet it’s notable that a middle income country made this health policy a priority even when it’s rich Northern neighbor has not.
![Page 13: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/13.jpg)
HEALTHCARE IN MEXICO
![Page 14: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/14.jpg)
Competitive Private Health Care System
• The cost of medical care services vary by hospital, by physician, or by the seriousness of one’s condition.
• On average, an office visit to a doctor, including a specialist, could cost between 250 and 500 pesos (US$21 to $40).
• Lab tests could cost about one-third of the comparative cost in the United States.
• CAT scans are 25% cheaper than in the US. • Overnight stays in a private hospital room start at about $500
pesos (US$40) only.• Visiting the dentist for a regular teeth cleansing will cost
about three hundred pesos (US$22).
![Page 15: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/15.jpg)
Source: Health Ministry
+ 50% of hospitals in Mexico are certified+ 8 private hospitals are certified by the Joint Commission International (JCI)
![Page 16: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/16.jpg)
Source: Health Ministry
![Page 17: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/17.jpg)
Source: Health Ministry
![Page 18: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/18.jpg)
Source: Health Ministry
![Page 19: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/19.jpg)
Biosciences
• Unfortunately, Biosciences as a business are linked to Big Pharma
• Big Pharma could not care less for helping Mexico grow– Mexico is a market to be exploited: huge
population, wide social security coverage, dubious and bureaucratic purchasing systems
– Mexicans make excellent clinical case study subjects, if you can deal with the socialized medical system
![Page 20: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/20.jpg)
Mexico Pharmaceuticals Trade(MUSD)
![Page 21: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/21.jpg)
Market Liberalisation• Automedication: 70 % of population takes drugs not
prescribed by their doctors• Low integration levels for production chains: no
access to competitively priced raw materials• Illegal imports through Tijuana• Imports of antiretrovirals released in August 2008. • Imports of vitamins, homeopathic medicines,
vaccines, sera, haemoderivatives, antitoxins and biologic hormones released in February 2009.
• Producers of other biologics (eg insulin and erythropoietin) export to Mexico since August 2009.
![Page 22: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/22.jpg)
Market Liberalisation• Narcotic or psychotropic drugs and OTC drugs liberated in
February 2010.• Local manufacturing plant requirements phased out over
two year period: Market fully open by mid 2010• Competition expected to grow from middle sized foreign
producers who did not have the resources to invest in manufacturing in Mexico
• Only patented and bioequivalent generic drugs in the market as from 24th February 2010.
• 17% of the 10,500 pharmaceuticals whose registrations need to be renewed by the Federal National Commission for Protection against Health Risks (COFEPRIS), will probably exit the market
![Page 23: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/23.jpg)
Forget about Big Pharma• Bring in Middle and Little Pharma!• FDI• Strong European presence• Great Veterinary Market• Promote Joint Ventures with Mexican Pharma• Liaison with excellent national and local research
centers throughout Mexico• The best research done in Mexico is in the Health
Sciences• If there is again a Nobel Prize made in Mexico it will be
in Medicine/Physiology
![Page 24: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/24.jpg)
Growing Number of Researchers in Biosciences and Healthcare
Source: CONACYT
![Page 25: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/25.jpg)
Federal Programs Supporting innovation
• AVANCE• Fiscal Incentives• New Fund for Science and Technology• Incentive Programs for Innovation• IDEA• IBEROEKA• FONCICYT• Bilateral Technological Cooperation with Spain, France• Sabbatical Stay in Industry• Innovation Networks• Innovation Stimulus Programme and Fund• Sectorial Funds (CONACYT-Ministries of State)• Regional Funds (CONACYT)
Source: CONACYT
![Page 26: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/26.jpg)
Research
ResearchersResearchers 2,120
ProtocolsProtocols 650
Source: CANIFARMA
![Page 27: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/27.jpg)
Clinical Research
• Around 12 companies engage in clinical research because it provides:– Local experience – Capability to meet with certain regulations.
• Around 10 pharmaceutical companies do research to acquire local experience in the clinical area.
• To a lesser degree, four or five companies do research after marketing their products, due to differences in the pharmacogenomic profile of the local population and because of differences in the medical practice.
• Small US presence
![Page 28: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/28.jpg)
What next? Medical Tourism
• We have to demitify Medical Tourism• More research needed • Perhaps NADBANK can fund or help fund an
initiative between Guadalajara and San Antonio
![Page 29: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/29.jpg)
Arguments to promote Medical Tourism to Mexico
• Most of the health care practitioners in Mexico have been trained in Mexico and other western countries.
• Mid-sized and larger cities in Mexico have at least one first-rate hospital and the cost of healthcare is generally lower than one might expect to pay in the US.
• A lot of North Americans travel to Mexico for dental work or minor surgeries (Medical Tourism)
• The same applies for prescription drugs. On average, prescription drugs that are manufactured in Mexico are about 50% cheaper compared to similar drugs manufactured in the United States.
![Page 30: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/30.jpg)
What Next: Research opportunities in Mexico
• Pharmacologic applications of natural compounds
• Biotechnology and genomics• Improvement of known molecules• Support of global research• Technology research
![Page 31: Biosciences and Healthcare Dr. Francisco Medina Gómez Jalisco State Council of Science and Technology (COECYTJAL) San Antonio, Texas, November 16th, 2012](https://reader035.vdocument.in/reader035/viewer/2022062219/551be7dc550346b4588b616a/html5/thumbnails/31.jpg)
The future• The writing is on the wall• Most of what could be accomplished through trade
has been done. Welcome to Diminishing Returns!• Very little cooperation has taken place, whether at
the academic level or the SME level. • Neither CONACYT or the National Science
Foundation have worked together to define a common R&D Agenda and the Partnership for Prosperity was a fluke
• Mexico City, Washington, D.C., Ottawa, move over! It is time for the locals, specially the cities– Knowledge about each other brings understanding.– Understanding brings agreements– Agreements bring actions– Actions bring results